Pavmed vs Qtrex Quantum
Qtrex Quantum is the larger business, with $289,000 of revenue in fiscal 2025 against $71,000 for Pavmed (4.1 times as much). Pavmed kept more of each dollar of sales as profit: a net margin of 564.8% against -4574.4%. Qtrex Quantum carries less debt relative to equity (0.0% against 23.1%).
| Latest fiscal year | PavmedPAVM, 2025 | Qtrex QuantumQTEX, 2025 |
|---|---|---|
| Revenue | $71,000 | $289,000 |
| Revenue growth | -97.6% | — |
| Net income | $401,000 | −$13.2m |
| Operating margin | -30712.7% | -4713.8% |
| Net margin | 564.8% | -4574.4% |
| Return on equity | 2.5% | — |
| Free cash flow | −$5.2m | −$10.0m |
| Cash | $1.5m | $3.2m |
| Total debt | $7.8m | $0 |
| Debt to equity | 23.1% | 0.0% |
| Dividend per share | — | — |
| Dividend yield | — | — |
| Share buybacks | — | — |
| Employees | 41 | — |
| Market value | $11.7m | $40.6m |
| Price vs our value range | — | — |
| Moat score | 20 (Weak) | — |
| Insider trades, 12 months | 0 buys, 0 sales | 4 buys, 7 sales |